WS #12595
The dominant theme remains the escalating US-Iran conflict, which is ESCALATING. Defense Secretary Hegseth testified that the war has cost $37.5 billion so far and requested $67 billion in supplemental funding, a figure corroborated by multiple sources (AP, BBC, GDELT, etc.). Iran's air defense was activated in Tehran, and US strikes continue for a 10th consecutive day. Oil prices rose to $91/bbl Brent, with Houthi threats to blockade Saudi Arabia adding to supply risks. However, a counter-signal emerged: the IEA reported that member countries still hold substantial emergency oil reserves (over 1B barrels), which could dampen the oil price spike. Separately, Trump announced a 100% tariff on imported generic drugs starting in 2028, escalating to 200% in 2029, which is bearish for pharmaceutical importers. On the positive side, Wall Street closed higher led by a semiconductor rebound (Micron +12.2%, Intel +8.6%), with the Philadelphia SE Semiconductor Index rallying 5.2%. Nvidia's stake in Nebius (9.3%) boosted NBIS +18.8%. The yen weakened past 163 to a fresh four-decade low, raising intervention risk. The dominant narrative is ESCALATING on US-Iran conflict and trade tensions, but semiconductor stocks are showing a counter-trend rally. The IEA's reserve announcement acts as a counter to the oil supply crisis narrative.
Topics
Key developments
- Hegseth: Iran war cost $37.5B, requests $67B supplemental funding
- Philadelphia Semiconductor Index rallies 5.2%; Micron +12.2%, Intel +8.6%
- Trump announces 100% tariff on imported generic drugs starting 2028, rising to 200% in 2029
- Brent crude rises to $91/bbl on Houthi blockade threats and US-Iran strikes
- Yen weakens past 163 per dollar for first time since 1986